How much does York Bioanalytical Solutions Limited make?

York Bioanalytical Solutions Limited reported revenue of £11.1m and £3.6m profit in the year to 31 Dec 2024, according to its accounts filed at Companies House.

How many employees does York Bioanalytical Solutions Limited have?

York Bioanalytical Solutions Limited reported an average of 82 employees in the year to 31 Dec 2024.

Is York Bioanalytical Solutions Limited profitable?

Yes — York Bioanalytical Solutions Limited reported a profit of £3.6m in the year to 31 Dec 2024.

Company No. 03776816 · Incorporated 25 May 1999

York Bioanalytical Solutions Limited

Registered name: YORK BIOANALYTICAL SOLUTIONS LIMITED

York Bioanalytical Solutions Limited made £11.1m revenue and £3.6m profit in the year to 31 Dec 2024. read from filing text

York Bioanalytical Solutions Limited’s revenue grew 2% to £11.1m in the year to 31 Dec 2024, with £3.6m profit and 82 employees. The company is classified under “other research and experimental development on natural sciences and engineering” and is based in Upper Poppleton York; we hold 3 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 72190Other research and experimental development on natural sciences and engineering

Status: Active
Location: Upper Poppleton York, Yorkshire and The Humber
Age: 27 yrs · since 1999
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company's immediate parent undertaking is York Bioanalytical (Holdings) Limited, a company incorporated in the United Kingdom.”

Latest accounts · year to 31 Dec 2024

Key figures

Operating leverage

Revenue

£11.1m

Growth ▲2.2%

Profit

£3.6m

Growth ▲52.3%

Profit margin

32.9%

Gross 47.6%

Employees

Change ▲1.2%

Profit / employee

£44.3k

Revenue/employee £135k

Profitable streak

3yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024
Disclosure	Full P&Lread from filing text	Full P&Lread from filing text	Full P&Lread from filing text
Profit & loss
Revenue (turnover)	£8.5m	£10.8m	£11.1m
Cost of sales	£4.8m	£5.6m	£5.8m
Gross profit	£3.7m	£5.3m	£5.3m
Operating profit	£2.4m	£2.5m	£4m
Profit before tax	£2.5m	£3.1m	£4.8m
Profit after tax	£2m	£2.4m	£3.6m
Profit (best available)	£2m	£2.4m	£3.6m
Employees (average)	75	81	82
Ratios
Profit margin	24%	22%	32.9%
Gross margin	43.5%	48.6%	47.6%
Revenue per employee	£113k	£134k	£135k
Profit per employee	£27.1k	£29.4k	£44.3k
Growth (year on year)
Revenue growth	—	▲27.4%	▲2.2%
Profit growth	—	▲17.2%	▲52.3%
Headcount growth	—	▲8%	▲1.2%
Balance sheet — indirect signals, not revenue
Cash at bank	£8.8m	£11.6m	£18.6m
Net assets	£19.1m	£21.5m	£25.2m
Fixed assets	£3m	£3.1m	£2.8m
Current assets	£19.7m	£22.8m	£27.7m
Debtors	£1.7m	£2.4m	£1.7m
Deferred income	£814k	£915k	£955k
Source	FullAccounts · bulk data Dec 2024	FullAccounts · bulk data Dec 2024	FullAccounts · bulk data Dec 2025

Derived from the latest filing

How the business works

Profit margin: 32.9%; Profit ÷ revenue.
Gross margin: 47.6%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £135k; Revenue ÷ average employees.
Profit per employee: £44.3k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 25.5%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 8.6%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 15.7%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲17%; Now £25.2m
Cash at bank: ▲60%; Now £18.6m
Headcount: ▲1%; Now 82
Deferred income: ▲4%; Now £955k
Fixed assets: ▼9%; Now £2.8m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Minority corporate shareholders

Unilabs Laboratoire D' Analyses Medicales Sa (registered outside the UK register)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2024 (profit £3.6m), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Updated from Companies House on 13 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.